Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferrario

Showing results (341-350 of 828) with videos related to

Pageof 83
Sort By:
Regulatory Peptides|March 19, 1992
Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neuronesP Ambühl, D Felix, H Imboden, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1996
Angiotensin-(1-7) inhibits vascular smooth muscle cell growthE J Freeman, G M Chisolm, C M Ferrario, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1996
Salt-sensitive hypertension in (mREN-2)27 transgenic ratsM F Callahan, P Li, C M Ferrario, et al.
Optics Express|February 3, 2016
Measurement of power spectral density of broad-spectrum visible light with heterodyne near field scattering and its scalability to betatron radiationM Siano, B Paroli, E Chiadroni, et al.
Journal of the American Society of Nephrology : JASN|September 4, 1998
Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresisC M Ferrario, M C Chappell, R H Dean, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Effect of Na+/H+ exchange inhibitors on agonist-induced contraction of rat aortaE E Reynolds, J M Brum, E J Cragoe, et al.
La Medicina Del Lavoro|January 1, 1982
[Work and stress - instruments and methods for an epidemiological investigation on risk factors and cardiovascular disease (author's transl)]R Zanettini, G C Cesana, R Curti, et al.
Therapeutic Advances in Cardiovascular Disease|June 18, 2015
Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failurePeng Zhou, Che Ping Cheng, Tiankai Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregationP Li, M Fukuhara, D I Diz, et al.
Angiology|August 1, 1995
Angiotensin II pressor activity depends on medial and lateral anterior hypothalamic pathwaysH Kawabe, O U Lopes, K B Brosnihan, et al.
Pageof 83

Showing results (341-350 of 828) with videos related to

Sort By:
Pageof 83
Regulatory Peptides|March 19, 1992
Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neuronesP Ambühl, D Felix, H Imboden, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1996
Angiotensin-(1-7) inhibits vascular smooth muscle cell growthE J Freeman, G M Chisolm, C M Ferrario, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1996
Salt-sensitive hypertension in (mREN-2)27 transgenic ratsM F Callahan, P Li, C M Ferrario, et al.
Optics Express|February 3, 2016
Measurement of power spectral density of broad-spectrum visible light with heterodyne near field scattering and its scalability to betatron radiationM Siano, B Paroli, E Chiadroni, et al.
Journal of the American Society of Nephrology : JASN|September 4, 1998
Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresisC M Ferrario, M C Chappell, R H Dean, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Effect of Na+/H+ exchange inhibitors on agonist-induced contraction of rat aortaE E Reynolds, J M Brum, E J Cragoe, et al.
La Medicina Del Lavoro|January 1, 1982
[Work and stress - instruments and methods for an epidemiological investigation on risk factors and cardiovascular disease (author's transl)]R Zanettini, G C Cesana, R Curti, et al.
Therapeutic Advances in Cardiovascular Disease|June 18, 2015
Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failurePeng Zhou, Che Ping Cheng, Tiankai Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregationP Li, M Fukuhara, D I Diz, et al.
Angiology|August 1, 1995
Angiotensin II pressor activity depends on medial and lateral anterior hypothalamic pathwaysH Kawabe, O U Lopes, K B Brosnihan, et al.
Pageof 83